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Abstract The synthesis of structurally new carbohydrate-O-heterocycles 
molecules with various unsaturated carbon bridge has been accomplished by 
palladium catalyzed cross-coupling reaction. 
Key words O-heterocycles, Heck-Mizoroki reaction, methylene, vinyl, 
carbohydrate 
 
Flavonoids represent a notable group of phenolic plant 
components. Usually, these flavonoids are bioactive compounds 
and their beneficent properties have been observed for a long 
while. Nowadays, their bioavailability, metabolic ability, and 
detailed health effects have been studying in numerous medical 
researches.1a Since flavonoids are potent antioxidants in vitro, 
these compounds are in the main interests of the investigation 
of e. g. protection against cardiovascular disease. Further, these 
natural compounds often contain a carbohydrate moiety in 
different position on the skeleton. Especially, C-glycosyl 
flavonoids show wide and interesting biological activities such 
as antiviral,1b cytotoxic,2 anti-inflammatory3 and DNA binding 
activities.4 Therefore, our research is focused on the synthesis of 
new compounds of flavones/chromone (1) and 
flavanones/chromanones (2) by Heck-Mizoroki reactions, 
applying carbohydrates with a vinyl or a methylene group at 
different position at a furanose or a pyranose ring.  
First, the synthesis of 5,6-dideoxy-1,2-O-isopropylidene-α-D-
xylo-hex-5-enofuranose (3) was performed and then the 
substrates scope was surveyed. Furanose 3 was formed in 49% 
yield using a literature procedure5 (I2/TTP/imidazole/dry 
CH2Cl2/ 0°C to rt/ 2h) to afford terminal alkene 3. 
The reactions of vinyl furanose 3 and bromo derivatives 1a,b, 
under a phosphine free Jeffery’s condition,6a provided the 
corresponding compounds 4a,b in 79% and 70% yield as trans 
isomers, respectively (Scheme 1, Table 1). However, if the 
amount of the Bu4NBr was halved or 2 equiv Bu4NCl was applied 
instead of 2 equiv Bu4NBr; only dehalogenation was observed 
and flavone was isolated in ~30-40% yields. 
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Scheme 1 
Table 1 Yields of reaction compound 3 under Jeffery condition  
Reactant Condition Time Product Yield 
7-bromoflavone Jeffery 3h 4a 79%a 
6-bromoflavone Jeffery 4h 4b 70% 
7-bromochromone Jeffery 3h 4c 71% 
6-bromochromone Jeffery 4h 4d 72% 
7-bromochromanone Jeffery* 1h 5a 10%b 
7-bromoflavanone Jeffery* 1h 5b 33%c 
6-bromochromanone Jeffery* 1h 5c 20% 
Jeffery: 1 equiv substrate, 1 equiv ArBr, 6% Pd(OAc)2, 1 equiv KCl, 2 equiv Bu4NBr, 
1.5 equiv K2CO3, dry DMF, 100°C, N2 atmosphere. Jeffery*: 1 equiv substrate, 1 
equiv ArBr, 6% Pd(OAc)2, 2 equiv Bu4NBr, 1.5 equiv HCOONa, solvent, 100°C, N2 
atmosphere; a using 1 equiv Bu4NBr or 2 equiv Bu4NCl yield is 0%, only 
dehalogenation occurred in 30-40% yield;  b: conversion 19%, c: flavone and 
chalcone mixture 
 
The bromochromones 1c,d showed identical stereoselectivity 
and the yields (4c: 71%, 4d: 72%) were comparable with the 
reactions of bromoflavones. However, the chromanone 
derivatives decomposed under these conditions. Since these O-
heterocycles are base sensitive compounds, the application of 
HCOONa6b proved to be a key to solve this problem. Hence, the 
syntheses of chromanone derivatives 2a,c and flavanone 2b 
were managed to attain in low yields (10-33%). The reaction of 
vinyl furanose 3 with different oxygen containing heterocycles 
showed only trans stereoselectivity. 
In order to prepare a disubstituted compound, 7-bromo-6-
triflyloxyflavone (6a) was involved in the study, since this 
compound has two substituents which can take part in the 
cross-coupling reaction (Scheme 2, Table 2). 
 
Scheme 2 
Table 2 Results of reactions of triflates derivative 6a and compound 6b 
Reactant Condition Time Product Yield 
7-bromo-6-
triflyloxyflavone 
Jeffery 1h 7b 44% 
7-bromo-6-
hydroxyflavone 
Jeffery 3h 7b no 
reaction 
Jeffery: 1 equiv substrate, 1 equiv ArBr, 6% Pd(OAc)2, 1 equiv KCl, 2 equiv Bu4NBr, 
1.5 equiv K2CO3, DMF, 100°C, N2 atmosphere. 
 
In different palladium catalyzed reactions, the application of a 
pseudo halide (OTf) is well known in the literature. Thus, we 
envisioned that these transformations could be selectively 
controlled at various stages to afford the desired products by 
tuning the reaction parameters. The reaction proceeded 
smoothly but compound 7a was not detected in the reaction 
mixture only the hydrolyzed derivative 7b was isolated in 44% 
yield. In order to investigate whether the hydrolysis or the 
cross-coupling reaction occurred first, the reaction of 7-bromo-
6-hydroxyflavone (6b) was carried out, but no transformation 
was occurred (Scheme 2). It means, the cross-coupling reaction 
was successful, and then the formed product 7a was hydrolyzed 
to 7b. 
In order to further broaden the scope of this reaction with 
respect to the O-heterocycle components, we employed a 
bromocoumarin 8 as well as -aurone 10 in this process, and 
each of the desired compounds were formed in moderate to 
good yields (9: 86%, 11: 47%) (Scheme 3). 
 
Scheme 3  
Table 3 Yields of coumarine 8 and aurone 10 derivatives 
Reactant Condition Time Product Yield  
6-bromocoumarine Jeffery 4h 9 86% 
5-bromoaurone Jeffery 3h 11 47% 
Jeffery: 1 equiv substrate, 1 equiv ArBr, 6% Pd(OAc)2, 1 equiv KCl, 2 equiv Bu4NBr, 
1.5 equiv K2CO3, DMF, 100°C,N2 atmosphere 
 
 
Scheme 4  
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The synthesis of another ‘vinyl-sugar’ 12 was achieved12 from 
1,2:5,6-di-O-isopropylidene-α-D-ribo-hexulofuranos-3-ulose 
with vinylmagnesium bromide via Grignard reaction, however 
this reaction afforded the product 12 in low yield. Therefore, 
only one cross-coupling reaction was performed with flavone 1a 
and 3-C-ethenyl-1,2:5,6-bis-O-(1-methylethylidene)-α-D-
allofuranose (12), giving the desired product 13 in good yield 
(56%) (Scheme 4). The applied conditions did not cause the 
cleavage of the acetal protecting groups. 
After these promising results regarding to the furanose 
compounds, we began the investigation of the ‘vinyl-pyranose’ 
derivatives 14,7 168 in palladium catalyzed reactions. 
Palladium-catalyzed Heck reaction6c of 1a and methyl 6,7-
dideoxy-4-O-(2-naphthalenylmethyl)-2,3-bis-O-(phenylmethyl)-
α-D-gluco-hept-6-enopyranoside (14) using Pd(OAc)2/Ph3P as 
catalyst-ligand pair was used to afford the desired 15a in 49% 
yield under these classical Heck condition. 
 
Scheme 5  
Table 4 Yields of reactions of haloflavones/chromones 1 
Reactant Condition Product Yield 
7-bromoflavone Heck 15a 49% 
7-bromoflavone B 15a 30% 
7-bromoflavone A 15a 59% 
7-bromoflavone A* 15a 84% 
6-bromoflavone A* 15b 86% 
6-iodoflavone B* 15b 74% 
7-bromochromone A* 15c 50% 
6-bromochromone A* 15d 49% 
Heck conditions: 1 equiv substrate, 1 equiv ArBr, 6% Pd(OAc)2, 1.1 equiv 
triethylamine (TEA), 10% triphenylphosphine (TPP), NMP, 100-110 °C/N2 atm, 3h 
A conditions: 1 equiv substrate, 1 equiv ArBr, 6% Pd(OAc)2, 1 equiv KCl, 2 equiv 
Bu4NBr, 1.5 equiv K2CO3, DMF, 100°C, 3 h, N2 atmosphere.  
B conditions: 1 equiv substrate, 1 equiv ArBr, 6% Pd(OAc)2, 1 equiv KCl, 2 equiv 
Bu4NBr, 1.5 equiv HCOONa, DMF, 100°C, 3 h, N2 atmosphere, 3h 
A* conditions: 1 equiv substrate, 1 equiv ArBr, 6% Pd(OAc)2, 1 equiv KCl, 2 equiv 
Bu4NBr, 1.5 equiv K2CO3, 10% AgNO3, DMF, 100°C, 3 h, N2 atmosphere 
B* conditions: 1 equiv substrate, 1 equiv ArBr, 6% Pd(OAc)2, 1 equiv KCl, 2 equiv 
Bu4NBr, 1.5 equiv HCOONa, 10% AgNO3, DMF, 100°C, 3 h, N2 atmosphere 
 
While the previously successfully used phosphine free Jeffery’s 
condition (Pd(OAc)2, HCOONa, TBAB, KCl) resulted the same 
product in 30% yield. It is known from the literature, the 
application of silver(I) salts can increase the efficiency of the 
cross-coupling reactions.13 Therefore, 10% AgNO3 was applied 
as an additive in the reaction and the yield was doubled (59%). 
If we used K2CO3 as base the yield was increased up to 84%. In 
case of 1b the coupled derivative 15b was isolated in 86% yield. 
It is well known iodo compounds can react more readily than 
bromo one. Whereas, we carried out the cross coupling reaction 
of 6-iodoflavone (1e) and 14 and even using a weaker base 
(HCOONa) the product was isolated in good yield (74%) due to 
the increased reactivity of O-heterocyclic compound. The 
phosphine free condition with K2CO3 worked well in case of 
bromochromones 1c,d and the transformation successfully 
afforded the chromone-glucopyranoside derivatives 15c,d 
(50%; 49% respectively). The applied conditions were suitable 
to keep the ether type protecting groups (Scheme 5). 
In the survey another pyranoside type compound was tested, 
namely the 6,7-dideoxy-4-O-[(4-methoxyphenyl)methyl]-2,3-
bis-O-(phenylmethyl)-1-phenylthio--D-gluco-hept-6-
enopyranoside (16). 
 
Scheme 6  
Table 5 Cross-coupling reactions of pyranose 16 
Reactant Conditions Product Yield 
7-bromoflavone A* 17a 70% 
6-bromoflavone A* 17b 68% 
6-iodoflavone A* 17b 88% 
A* conditions: 1 equiv substrate, 1 equiv ArBr, 6% Pd(OAc)2, 1 equiv KCl, 2 equiv 
Bu4NBr, 1.5 equiv K2CO3, 10% AgNO3, DMF, 100°C, 3 h, N2 atmosphere 
 
This compound was available in limited amount, because of this 
reason it was reacted only with haloflavones. 7- and 6-
bromoflavone (1a,b) and 6-iodoflavone (1e) were used; under 
the phosphine free Jeffery condition (AgNO3, K2CO3) the 
products 17a-e were obtained in good  yields (70-88%) 
(Scheme 6). 
To increase the variety of the carbohydrate compounds; 1,2:5,6-
di-O-isopropylidene-3-methylene-α-D-allofuranose (18) was 
synthetized,8-11 and then used in further reactions. The 
preparation of compound 18 started from the 1,2:5,6-di-O-
isopropylidene-α-D-glucofuranose, which compound was 
oxidized by Swern oxidation to afford the 1,2:5,6-di-O-
isopropylidene-α-D-ribo-hexulofuranos-3-ulose. The isolated 
product was converted into 1,2:5,6-di-O-isopropylidene-3-
methylene-α-D-allofuranose (18) by the treatment of 
methyltriphenylphosphonium bromide. 
First, the Jeffery’s conditions were tested with 7-bromo-, 6-
bromoflavones (1a,b) as substrates. 
 
Scheme 7  
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Table 6 Cross-coupling reactions of pyranose 18 
Reactant Conditio
n 
Tim
e 
Produ
ct 
Yiel
d 
(Z) 
Yiel
d 
(E) 
7-bromoflavone Jeffery 3h 19a 33% 30% 
6-bromoflavone Jeffery 4h 19b 37% 37% 
7-
bromochromone 
Jeffery 3h 19c 14% 15% 
6-
bromochromone 
Jeffery 3h 19d 28% 27% 
7-
bromochromanon
e 
Jeffery* 1h 20a 14% - 
Jeffery: 1 equiv substrate, 1 equiv ArBr, 6% Pd(OAc)2, 1 equiv KCl, 2 equiv Bu4NBr, 
1.5 equiv K2CO3, DMF, 100°C, N2 atmosphere. Jeffery*: 1 equiv substrate, 1 equiv 
ArBr, 6% Pd(OAc)2, 2 equiv Bu4NBr, 1.5 equiv HCOONa, solvent, 100°C, N2 
atmosphere 
 
The 2D NMR measurements of the separated compounds 
revealed that during the reaction Z and E isomers were formed 
approximately in 1:1 ratio (Z-19a = 33%, E-19a =30%) (Scheme 
15). Similar observation was found in case of 6-bromoflavone 
(Z-19b= 37%, E-19b =37%).  
Then, the cross coupling reaction of bromochromones 1c,d  and 
18 was performed using the Jeffery’s methods. The chromone 
derivatives also provided the cis and trans isomers in moderate 
yields (Z-19c= 14%, E-19c=15%; 6-bromochromone: Z-19c= 
27%, E-19c=28%) in the same ratio as in the case of flavones. 
The reaction of 7-bromochromanone (2a) with the same 
carbohydrate derivative under modified Jeffery’s conditions 
resulted in the desired coupled product 20a, although the yield 
was low (14%) and only the trans isomer was formed (Scheme 
7). 
As a summary, in order to create unique compounds, which are 
new analogs of the naturally-occurring C-glycosyl flavonoids in 
good yields, we successfully performed the palladium catalyzed 
cross-coupling reactions of carbohydrates with vinyl and 
methylene group and different oxygen-heterocycles. In the 
frame of this project the Heck reaction of chromanones and 
flavanones were also investigated. We have found effective 
reaction conditions to transform these base sensitive 
compounds via Heck-Mizoroki reactions. In the case of isolated 
derivatives with vinyl linkers, we found high trans 
stereoselectivity. The reactions with methylidene group showed 
the formation of both isomers usually in 1:1 ratio. The biological 
assays already have been started with some selected 
derivatives. These structurally novel derivatives with various 
alkenyl spacers are interesting for biological tests and may 
provide new hits for pharmaceutical R&D by improving 
metabolism and adsorption properties compare to natural C-
glysosyl flavonoids. By this modern cross-coupling reaction, we 
managed to prepare such derivatives which synthesis is 
currently not solved on other pathways. 
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d][1,3]dioxol-6-yl)vinyl)-2-phenyl-4H-chromen-4-one (13) 
Yield: 141 mg (56%); white solid; mp 177–178 °C eluent: hexane–
EtOAc (1:1). IR (KBr): 1069, 1164, 1216, 1373, 1431, 1608, 1623, 
1640, 2986, 3451 cm−1. 1H NMR (400 MHz, CDCl3) δ 8.18 (d, J = 8.2 
Hz, 1H), 7.96 – 7.88 (m, 2H), 7.60 – 7.50 (m, 3H), 7.47 (d, J = 8.3 
Hz, 1H), 7.06 (d, J = 16.0 Hz, 1H), 6.81 (s, 1H), 6.39 (d, J = 15.9 Hz, 
1H), 5.93 (d, J = 3.7 Hz, 1H), 4.40 (d, J = 3.6 Hz, 1H), 4.25 – 4.15 (m, 
1H), 4.06 – 3.97 (m, 3H), 3.15 (s, 1H), 1.66 (s, 3H), 1.45 (s, 3H), 
1.39 (s, 3H), 1.31 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 178.1, 
163.5, 156.7, 142.1, 131.8, 131.7, 130.1, 129.9, 129.1, 126.3, 
126.1, 123.4, 123.3, 115.9, 113.4, 109.7, 107.8, 103.8, 83.8, 81.6, 
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2-phenyl-4H-chromen-4-one (15b). Yield: 245 mg (86%); 
white solid; mp 159–163 °C; eluent: hexane–EtOAc (3:1). IR 
(KBr): 696, 736, 1042, 1077, 1357, 1451, 1616, 1648, 2908, 3030 
cm−1. 1H NMR (360 MHz, CDCl3) δ: 8.14 (s, 1H), 7.91 (d, J = 7.6 Hz, 
1H), 7.30 (m, 23H), 6.84 (s, 1H), 6.73 (d, J = 15.9 Hz, 1H), 6.15 (dd, 
J = 15.9, 6.8 Hz, 1H), 4.64 (m, 7H), 4.25 (t, J = 8.2 Hz, 1H), 4.06 (t, J 
= 9.3 Hz, 1H), 3.58 (dd, J = 9.5, 3.5 Hz, 1H), 3.38 (m, 4H). 13C NMR 
(90 MHz, CDCl3) δ: 178.2, 163.3, 155.6, 138.7, 138.1, 133.8, 133.4, 
133.1, 132.9, 131.7, 131.6, 131.4, 131.3, 129.0, 128.4, 128.0, 
127.8, 127.6, 127.0, 126.3, 125.9, 125.8, 123.8, 123.3, 118.3, 
107.5, 98.2, 82.0, 79.9, 75.9, 75.3, 73.4, 71.1, 55.3.Anal. Calcd for 
C48H42O7: C, 78.88; H, 5.79. Found: C, 78.93; H, 5.81.  
7-((E)-2-((2R,3R,4S,5R)-4,5-bis(benzyloxy)-3-((4-
methoxybenzyl)oxy)-6-(phenylthio)tetrahydro-2H-pyran-2-
yl)vinyl)-2-phenyl-4H-chromen-4-one (17a). Yield: 136 mg 
(70%); white solid; mp 139–140 °C; eluent: hexane–EtOAc 
(2:1).IR (KBr): 1028, 1067, 1251, 1369, 1430, 1450, 1608, 1649, 
2901, 3005 cm−1. 1H NMR (360 MHz, CDCl3) δ: 8.17 (s, 1H), 7.93 
(m, 2H), 7.24 (m, 20H), 7.12 (d, J = 8.6 Hz, 2H), 6.74 (m, 4H), 6.31 
(dd, J = 16.0, 6.0 Hz, 1H), 4.74 (m, 6H), 4.53 (d, J = 10.9 Hz, 1H), 
3.96 (dd, J = 8.5, 6.1 Hz, 1H), 3.72 (t, J = 8.9 Hz, 1H), 3.68 (s, 3H), 
3.52 (t, J = 9.3 Hz, 1H), 3.40 (t, J = 9.3, 1H). 13C NMR (90 MHz, 
CDCl3) δ: 178.0, 163.4, 159.4, 156.5, 142.3, 138.2, 137.9, 133.5, 
132.1, 131.7, 131.6, 130.9, 129.9-127.7, 126.2, 125.9, 123.4, 123.1, 
115.7, 113.8, 107.7, 87.7, 86.5, 81.1, 80.9, 79.21, 76.0, 75.5, 74.9, 
55.1. Anal. Calcd for C50H44O7S: C, 76.12; H, 5.62. Found: C, 76.16; 
H, 5.66. 
6-((Z)-((3aR,5S,6aR)-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-
2,2-dimethyldihydrofuro[2,3-d][1,3]dioxol-6(5H)-
ylidene)methyl)-2-phenyl-4H-chromen-4-one (Z-19b). Yield: 
88 mg (37%); white solid; mp 114-116 °C; eluent: hexane–EtOAc 
(3:1). IR (KBr): 1019, 1068, 1354, 1371, 1381, 1453, 1613, 1646, 
2933, 2987 cm–1. 1H NMR (400 MHz, CDCl3) δ 8.30 (s, 1H), 8.03 (d, 
J = 8.7 Hz, 1H), 7.95 – 7.88 (m), 7.60 (d, J = 8.7 Hz, 1H), 7.53 (m, 
3H), 7.12 (s, 1H), 6.82 (s, 1H), 5.87 (d, J = 3.7 Hz, 1H), 5.13 (d, J = 
2.7 Hz, 1H), 4.80 (d, J = 6.1 Hz, 1H), 4.18 – 4.01 (m, 3H), 1.60 (s, 
3H), 1.49 (s, 3H), 1.47 (s, 3H), 1.44 (s, 3H). 13C NMR (100 MHz, 
CDCl3) δ 178.2, 163.5, 155.7, 140.3, 134.1, 133.4, 131.8, 131.7, 
129.1, 126.7, 126.4, 125.9, 123.9, 118.5, 112.7, 110.1, 107.6, 
105.2, 80.8, 79.1, 77.5, 67.4, 27.5, 27.3, 26.9, 25.7. Anal. Calcd for 
C28H28O7: C, 70.58; H, 5.92. Found: C, 70.60; H, 5.94. 
6-((E)-((3aR,5S,6aR)-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-
2,2-dimethyldihydrofuro[2,3-d][1,3]dioxol-6(5H)-
ylidene)methyl)-2-phenyl-4H-chromen-4-one (E-19b). Yield: 
88 mg (37%); white solid; mp 200-206 °C; eluent: hexane–EtOAc 
(3:1). IR (KBr): 1042, 1207, 1355, 1370, 1381, 1454, 1609, 1646, 
2932, 2987 cm–1. 1H NMR (400 MHz, CDCl3) δ 8.17 (s, 1H), 7.93 (d, 
J = 7.5 Hz, 2H), 7.78 (d, J = 8.6 Hz, 1H), 7.55 (m, 4H), 6.94 (s, 1H), 
6.84 (s, 1H), 5.93 (d, J = 4.4 Hz, 1H) 5.52 (s, 1H), 5.25 – 5.16 (m, 
1H), 4.11 (dd, J = 11.7, 6.1 Hz, 1H), 3.88 (t, J = 7.5 Hz, 1H), 3.59 (t, J 
= 7.7 Hz, 1H), 1.52 (s, 3H), 1.46 (s, 3H), 1.37 (s, 3H), 1.25 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 178.0, 163.6, 155.6, 140.8, 133.8, 
133.5, 131.8, 131.6, 129.1, 127.4, 126.4, 125.6, 124.0, 118.6, 
113.2, 109.9, 107.7, 103.9, 83.0, 79.7, 77.2, 65.9, 28.0, 27.9, 26.1, 
25.5. Anal. Calcd for C28H28O7: C, 70.58; H, 5.92. Found: C, 70.61; 
H, 5.94. 
c) Heck Condition: A stirred mixture of bromoflavone 1a (75 mg, 
0.249 mmol), 14 (0.249 mmol, 1.0 equiv), Et3N (39 l, 0.274 
mmol, 1.1 equiv), Ph3P (7 mg, 0.025 mmol, 10 mol%), and 
Pd(OAc)2 (4mg, 0.015 mmol, 6 mol%) in anhyd DMF (5 mL) was 
heated at 110°C for 2 h under N2. The mixture was cooled, silica 
gel was added, and the solvent was evaporated under reduced 
pressure. The residue was purified by column chromatography. 
7-((E)-2-((2R,3R,4S,5R,6S)-4,5-bis(benzyloxy)-6-methoxy-3-
(naphthalen-2-ylmethoxy)tetrahydro-2H-pyran-2-yl)vinyl)-
2-phenyl-4H-chromen-4-one (15a). Yield: 100 mg (70%); white 
solid; mp 151–153 °C; eluent: hexane–EtOAc (3:1). IR (KBr): 734, 
1050, 1068, 1367, 1430, 1622, 1646, 2925, 3030, 3060 cm−1. 1H 
NMR (360 MHz, CDCl3) δ: 8.06 (d, J = 8.2 Hz,  1H), 7.90 (m, 2H), 
7.54 (m, 7H), 7.22 (m, 15H), 6.85 (s, 1H), 6.68 (d, J = 15.9 Hz, 1H), 
6.20 (dd, J = 16.0, 6.5 Hz, 1H), 4.64 (m, 7H), 4.26 (t, J = 8.0 Hz, 1H), 
4.07 (t, J = 9.2 Hz, 1H), 3.58 (dd, J = 9.6, 3.5 Hz, 1H), 3.38 (m, 4H). 
13C NMR (90 MHz, CDCl3) δ: 178.1, 163.4, 156.4, 142.4, 138.6, 
138.1, 135.3, 133.1, 132.9, 131.7, 131.6, 130.9, 130.6, 129.0, 
128.5, 128.1, 128.0, 127.7, 127.5, 127.1, 126.3, 126.0, 125.9, 
125.8, 123.3, 123.0, 115.4, 107.6, 98.2, 81.9, 81.8, 79.9, 76.0, 75.4, 
73.5, 70.8. Anal. Calcd for C48H42O7: C, 78.88; H, 5.79. Found: C, 
78.90; H, 5.80. 
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